John M. Hamm is VP Chief Financial Officer of CUMBERLAND PHARMACEUTICALS INC. Currently has a direct ownership of 26,003 shares of CPIX, which is worth approximately $31,723. The most recent transaction as insider was on Mar 23, 2024, when has been sold 445 shares (Common Stock) at a price of $1.81 per share, resulting in proceeds of $805. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 26K
0% 3M change
2.97% 12M change
Total Value Held $31,723

John M. Hamm Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 23 2024
SELL
Payment of exercise price or tax liability
$805 $1.81 p/Share
445 Reduced 1.68%
26,003 Common Stock
Nov 27 2023
SELL
Payment of exercise price or tax liability
$587 $1.67 p/Share
352 Reduced 1.31%
26,448 Common Stock
Mar 16 2022
BUY
Grant, award, or other acquisition
$51,800 $2.59 p/Share
20,000 Added 42.74%
26,800 Common Stock
Nov 23 2021
BUY
Open market or private purchase
$8,930 $2.35 p/Share
3,800 Added 35.85%
6,800 Common Stock
JMH

John M. Hamm

VP Chief Financial Officer
Nashville, TN

Track Institutional and Insider Activities on CPIX

Follow CUMBERLAND PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CPIX shares.

Notify only if

Insider Trading

Get notified when an Cumberland Pharmaceuticals Inc insider buys or sells CPIX shares.

Notify only if

News

Receive news related to CUMBERLAND PHARMACEUTICALS INC

Track Activities on CPIX